Class 2 Medicines Recall: Fiasp FlexTouch 100 units/mL solution for injection pre-filled pen manufactured by Novo Nordisk (MDR 065-06/18)
Novo Nordisk is recalling one batch as a precautionary measure due to the presence of particles in a small number of samples.
Product information
Company name
Novo Nordisk
Product description
Fiasp FlexTouch 100 units/mL solution for injection pre-filled pen
(Insulin Aspart)
- Brand & Product Description: Fiasp FlexTouch 100 units/mL solution for injection pre-filled pen
- Batch Number: HP50949
- Pack Size: 5
- Date Released: 22/03/2018
Brief description of the problem
Novo Nordisk is recalling one batch as a precautionary measure due to the presence of particles in a small number of samples.
Advice for healthcare professionals
Stop dispensing the batch listed above. Return all remaining stock of this batch to your supplier using the supplier’s approved process. Novo Nordisk will also be circulating the letter attached to pharmacies.
This is a pharmacy level recall so there is no requirement to contact patients. If you receive queries about this issue from patients, however, please advise them to follow the advice given in the patient information leaflet regarding checking their insulin before use:
‘Check that the insulin in your pen is clear and colourless. Look through the insulin window. If the insulin looks cloudy, do not use the pen.’
Wholesalers
Quarantine any remaining stock of this batch and return to the original supplier for credit.
Company contacts for further information
Medical information enquiries
Novo Nordisk Customer Care
Tel: 0845 600 5055
Email:customercare@novonordisk.com
Stock enquiries
Novo Nordisk Customer Care
Tel: 0845 600 5055
Email:customercare@novonordisk.com
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS regional teams are asked to forward this to community pharmacists, hospital pharmacists and general practitioners for information.
Download document